Ann: ResApp Clears Major Milestone for CE and TGA with ISO 13485, page-22

Fantastic announcement and its come earlier than anticipated.

Risk vs reward is very compelling considering we are about to submit for TGA/CE clearance, along with FDA submissions for at least 3 diseases. Croup results expected by the months end - I believe it will be another positive result as it requires less subjectivity.

The biotech market has been punishing companies who fail to meet their primary endpoints. FTT this morning and MSB which found themselves in a similar situation to RAP.

The market will eventually do the sums and re-rate RAP swiftly. Plenty of upcoming newsflow.